BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16207477)

  • 1. Survey of differentially methylated promoters in prostate cancer cell lines.
    Wang Y; Yu Q; Cho AH; Rondeau G; Welsh J; Adamson E; Mercola D; McClelland M
    Neoplasia; 2005 Aug; 7(8):748-60. PubMed ID: 16207477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Promoter array" studies identify cohorts of genes directly regulated by methylation, copy number change, or transcription factor binding in human cancer cells.
    Wang Y; Hayakawa J; Long F; Yu Q; Cho AH; Rondeau G; Welsh J; Mittal S; De Belle I; Adamson E; McClelland M; Mercola D
    Ann N Y Acad Sci; 2005 Nov; 1058():162-85. PubMed ID: 16394135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.
    Sasaki M; Tanaka Y; Perinchery G; Dharia A; Kotcherguina I; Fujimoto Si; Dahiya R
    J Natl Cancer Inst; 2002 Mar; 94(5):384-90. PubMed ID: 11880477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer.
    Kim JH; Dhanasekaran SM; Prensner JR; Cao X; Robinson D; Kalyana-Sundaram S; Huang C; Shankar S; Jing X; Iyer M; Hu M; Sam L; Grasso C; Maher CA; Palanisamy N; Mehra R; Kominsky HD; Siddiqui J; Yu J; Qin ZS; Chinnaiyan AM
    Genome Res; 2011 Jul; 21(7):1028-41. PubMed ID: 21724842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.
    Yamamoto M; Cid E; Bru S; Yamamoto F
    PLoS One; 2011 Mar; 6(3):e17149. PubMed ID: 21423795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sulforaphane and 3,3'-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells.
    Wong CP; Hsu A; Buchanan A; Palomera-Sanchez Z; Beaver LM; Houseman EA; Williams DE; Dashwood RH; Ho E
    PLoS One; 2014; 9(1):e86787. PubMed ID: 24466240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells.
    Mishra DK; Chen Z; Wu Y; Sarkissyan M; Koeffler HP; Vadgama JV
    Mol Cancer Ther; 2010 Jan; 9(1):33-45. PubMed ID: 20053773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences.
    Yegnasubramanian S; Wu Z; Haffner MC; Esopi D; Aryee MJ; Badrinath R; He TL; Morgan JD; Carvalho B; Zheng Q; De Marzo AM; Irizarry RA; Nelson WG
    BMC Genomics; 2011 Jun; 12():313. PubMed ID: 21669002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
    Chakrabarti R; Robles LD; Gibson J; Muroski M
    Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.
    Kamradt J; Jung V; Wahrheit K; Tolosi L; Rahnenfuehrer J; Schilling M; Walker R; Davis S; Stoeckle M; Meltzer P; Wullich B
    PLoS One; 2007 Aug; 2(8):e769. PubMed ID: 17712417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer.
    Yamada Y; Watanabe M; Yamanaka M; Hirokawa Y; Suzuki H; Takagi A; Matsuzaki T; Sugimura Y; Yatani R; Shiraishi T
    Cancer Sci; 2003 Jun; 94(6):536-9. PubMed ID: 12824880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global reactivation of epigenetically silenced genes in prostate cancer.
    Ibragimova I; Ibáñez de Cáceres I; Hoffman AM; Potapova A; Dulaimi E; Al-Saleem T; Hudes GR; Ochs MF; Cairns P
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1084-92. PubMed ID: 20699414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
    Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B
    Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
    Singal R; van Wert J; Bashambu M
    Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene promoter methylation in prostate tumor-associated stromal cells.
    Hanson JA; Gillespie JW; Grover A; Tangrea MA; Chuaqui RF; Emmert-Buck MR; Tangrea JA; Libutti SK; Linehan WM; Woodson KG
    J Natl Cancer Inst; 2006 Feb; 98(4):255-61. PubMed ID: 16478744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.
    Pellacani D; Packer RJ; Frame FM; Oldridge EE; Berry PA; Labarthe MC; Stower MJ; Simms MS; Collins AT; Maitland NJ
    Mol Cancer; 2011 Jul; 10():94. PubMed ID: 21801380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array.
    Yu YP; Paranjpe S; Nelson J; Finkelstein S; Ren B; Kokkinakis D; Michalopoulos G; Luo JH
    Carcinogenesis; 2005 Feb; 26(2):471-9. PubMed ID: 15485992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer.
    Mitsui Y; Chang I; Kato T; Hashimoto Y; Yamamura S; Fukuhara S; Wong DK; Shiina M; Imai-Sumida M; Majid S; Saini S; Shiina H; Nakajima K; Deng G; Dahiya R; Tanaka Y
    Oncotarget; 2016 Aug; 7(31):49107-49121. PubMed ID: 27203547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.